Phthalocyanines as medicinal photosensitizers: Developments in the last five years
X Li, BD Zheng, XH Peng, SZ Li, JW Ying… - Coordination Chemistry …, 2019 - Elsevier
Owing to their high extinction coefficients, long absorption wavelengths, and modification
tunable photophysical and photochemical properties, phthalocyanines (Pcs) have been …
tunable photophysical and photochemical properties, phthalocyanines (Pcs) have been …
Biological characteristics and clinical significance of soluble PD-1/PD-L1 and exosomal PD-L1 in cancer
M Niu, Y Liu, M Yi, D Jiao, K Wu - Frontiers in Immunology, 2022 - frontiersin.org
The immune checkpoint pathway consisting of the cell membrane-bound molecule
programmed death protein 1 (PD-1) and its ligand PD-L1 has been found to mediate …
programmed death protein 1 (PD-1) and its ligand PD-L1 has been found to mediate …
Discovery of BLU-945, a reversible, potent, and wild-type-sparing next-generation EGFR mutant inhibitor for treatment-resistant non-small-cell lung cancer
MS Eno, JD Brubaker, JE Campbell… - Journal of medicinal …, 2022 - ACS Publications
While epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have
changed the treatment landscape for EGFR mutant (L858R and ex19del)-driven non-small …
changed the treatment landscape for EGFR mutant (L858R and ex19del)-driven non-small …
The secret ally: immunostimulation by anticancer drugs
It has recently become clear that the tumour microenvironment, and in particular the immune
system, has a crucial role in modulating tumour progression and response to therapy …
system, has a crucial role in modulating tumour progression and response to therapy …
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
S Wilhelm, C Carter, M Lynch, T Lowinger… - Nature reviews Drug …, 2006 - nature.com
Since the molecular revolution of the 1980s, knowledge of the aetiology of cancer has
increased considerably, which has led to the discovery and development of targeted …
increased considerably, which has led to the discovery and development of targeted …
Recent advances on quinazoline derivatives: A potential bioactive scaffold in medicinal chemistry
This paper intended to explore and discover recent therapeutic agents in the area of
medicinal chemistry for the treatment of various diseases. Heterocyclic compounds …
medicinal chemistry for the treatment of various diseases. Heterocyclic compounds …
Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies
M Hojjat-Farsangi - International journal of molecular sciences, 2014 - mdpi.com
Chemotherapeutic and cytotoxic drugs are widely used in the treatment of cancer. In spite of
the improvements in the life quality of patients, their effectiveness is compromised by several …
the improvements in the life quality of patients, their effectiveness is compromised by several …
[HTML][HTML] Quinoxaline: A comprehension of current pharmacological advancement in medicinal chemistry
SK Suthar, NS Chundawat, GP Singh… - European Journal of …, 2022 - Elsevier
Quinoxaline is a fused heterocycle ring template present in diverse pharmacophore and
widely used in medicinal chemistry. Owing to its vast pharmaceutical profile, several …
widely used in medicinal chemistry. Owing to its vast pharmaceutical profile, several …
Acceptorless Dehydrogenative Coupling of o-Aminobenzamides with the Activation of Methanol as a C1 Source for the Construction of Quinazolinones
F Li, L Lu, P Liu - Organic letters, 2016 - ACS Publications
A strategy for the synthesis of quinazolinones via acceptorless coupling of o-
aminobenzamides with methanol has been accomplished in the presence of the metal …
aminobenzamides with methanol has been accomplished in the presence of the metal …
Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors
Epidermal growth factor receptor (EGFR, also known as HER1) and HER2, prominent
members of receptor tyrosine kinase (RTK) superfamily, have been reported as diagnostic or …
members of receptor tyrosine kinase (RTK) superfamily, have been reported as diagnostic or …